<p>1. Pragmatism, Precision Oncology, International Partnership for Research and Quality-The New Paradigm for Thyroid Cancer </p><p>Ujjal Mallick, Clive Harmer</p><p>Section I. Multidisciplinary Approach to Management of Thyroid Cancer</p><p> 2. The UK Evidence-Based Guidelines for the Management of Thyroid Cancer: Key Recommendations</p><p>Maria G. Pavlatou, Sarah J Johnson, and Petros Perros</p><p>3. The 2015 American Thyroid Association Evidence-Based Guidelines for Management of Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Key Recommendations</p><p>Bryan R. Haugen</p><p>4. Thyroid Cancer: One Doctor-Patient Partnership -The Newcastle Butterfly Model</p><p>Kate A Farnell, RD Bliss, Ujjal K. Mallick</p><p>Section II. The Diagnosis of Thyroid Cancer</p><p>5. Molecular Diagnosis of Thyroid Nodules</p><p>David N. Poller </p><p>6. Ultrasonography in Diagnosis and Management of Thyroid Cancer –Current International Recommendations </p><p>Dong Gyu Na, Ji-Hoon Kim, Eun Ju Ha</p><p>Section III. Initial Thyroid Surgery</p><p>7. The 21st Century Endocrine Surgeon</p><p>Nadine R. Caron, Tracy S. Wang, Cord Sturgeon, Orlo H. Clark</p><p>8. Management of Cervical Lymph Nodes in Differentiated Thyroid Cancer</p><p>Hiro Ishii, Dae S. Kim, John C. Watkinson</p><p>9. Advances in Thyroid Surgery</p><p>Sara L. Richer, Dipti Kamani, GeorgeW. Randolph</p><p><br></p><p>Section IV. Non surgical Management of Differentiated Thyroid Cancer</p><p>10. Risk Stratification and Current Management of Low Risk Thyroid Cancer </p><p>Sana A. Ghaznavi, R. Michael Tuttle</p><p>11 Management of Low risk Papillary Thyroid Carcinomo and Papillary Cancer and Microcarcinoma-the Japanese experience</p><p>Yasuhiro Ito and Akira Miyauchi</p><p>12 Radioiodine Ablation – Current Status</p><p> Furio Pacini and Maria Grazia Castagna -- Sienna</p><p>13. Dosimetric Approaches – Current Concepts</p><p>Michael Lassmann, Markus Luster, Heribert Hanschield, Wurzberg, Germany</p><p>14. External Radiation in Differentiated Thyroid Cancer in the era of IMRT and modern radiation planning techniques</p><p>James D. Brierley, Meredith E. Giuliani</p><p>Section V. Follow up and Longterm Management of Differentiated Thyroid Cancer</p><p>15. Thyroglobulin</p><p>Shireen Fatemi, Carole Spencer</p><p>16. Management of Post-Operative Hypocalcemia </p><p>Claudio Marcocci</p><p>17. Radioiodine Refractory Thyroid Cancer </p><p>Berdelou A, Leboulleux S, Schlumberger M</p><p>Section VI. Medullary Thyroid Carcinoma</p><p>18. Medullary Thyroid Cancer :Surgical Management</p><p>Anna I. Kaleva ,A R Shaha, and Iain J. Nixon</p><p>19. Medullary Thyroid Cancer: Diagnosis and Non Surgical Management</p><p>Rossella Elisei, Antonio Matrone</p><p>20. Familial Non-Medullary Thyroid Cancer </p><p>Joanna Klubo-Gwiezdzinska, Yevgenia Kushchayeva, Sudheer Kumar Gara, Electron Kebebew </p><p>Section VII. Thyroid Cancer in Children</p><p>21. Pediatric Differentiated Thyroid Carcinoma</p>Steven G. Waguespack, Jonathan D. Wasserman<p></p><p>Section VIII. Aggressive Thyroid Cancers</p><p>22. Anaplastic Thyroid Cancer</p><p>Robert C. Smallridge, John Dr. Casler, and Michael E. Menefee</p><p>23. Palliative care</p><p>Mary Comiskey</p><p>Section IX. Future Developments and Directions for Research in Thyroid Cancer. </p><p>24. Translational Research and Genomics Driven Trials in Thyroid Cancer</p><p>Maria E. Cabanillas, Rebecca E. Schweppe, Ramona Dadu, Gilbert Cote, Thomas C. Beadnell, Marie Claude Hofmann</p><p>25. Thyroid Cancer Trials </p><p> Allan Hackshaw</p><p>26. The Barriers to Uniform Implementation of Clinical Practice Guidelines (CPG) for Thyroid Cancer</p><p>Ujjal Mallick, Fabian Pitoia</p><p>27. Survivorship: The Role of the Clinical Psychologist and the Clinical Nurse Specialist in Thyroid Cancer Care</p><p>Katherine Kendell, Nicola Jane Armstrong</p><div><br></div>